In vitro safety and anti‐bacterial efficacy assessment of acriflavine

Detalles Bibliográficos
Autores principales: Javadiyan, Shari, Germein, Kitty C., Cooksley, Clare M., Ramezanpour, Mahnaz, Singh, Narinder, Wormald, Peter‐John, Vreugde, Sarah, Psaltis, Alkis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311691/
https://www.ncbi.nlm.nih.gov/pubmed/35322438
http://dx.doi.org/10.1111/all.15289
_version_ 1784753654925885440
author Javadiyan, Shari
Germein, Kitty C.
Cooksley, Clare M.
Ramezanpour, Mahnaz
Singh, Narinder
Wormald, Peter‐John
Vreugde, Sarah
Psaltis, Alkis J.
author_facet Javadiyan, Shari
Germein, Kitty C.
Cooksley, Clare M.
Ramezanpour, Mahnaz
Singh, Narinder
Wormald, Peter‐John
Vreugde, Sarah
Psaltis, Alkis J.
author_sort Javadiyan, Shari
collection PubMed
description
format Online
Article
Text
id pubmed-9311691
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93116912022-07-29 In vitro safety and anti‐bacterial efficacy assessment of acriflavine Javadiyan, Shari Germein, Kitty C. Cooksley, Clare M. Ramezanpour, Mahnaz Singh, Narinder Wormald, Peter‐John Vreugde, Sarah Psaltis, Alkis J. Allergy Letters John Wiley and Sons Inc. 2022-03-31 2022-06 /pmc/articles/PMC9311691/ /pubmed/35322438 http://dx.doi.org/10.1111/all.15289 Text en © 2022 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters
Javadiyan, Shari
Germein, Kitty C.
Cooksley, Clare M.
Ramezanpour, Mahnaz
Singh, Narinder
Wormald, Peter‐John
Vreugde, Sarah
Psaltis, Alkis J.
In vitro safety and anti‐bacterial efficacy assessment of acriflavine
title In vitro safety and anti‐bacterial efficacy assessment of acriflavine
title_full In vitro safety and anti‐bacterial efficacy assessment of acriflavine
title_fullStr In vitro safety and anti‐bacterial efficacy assessment of acriflavine
title_full_unstemmed In vitro safety and anti‐bacterial efficacy assessment of acriflavine
title_short In vitro safety and anti‐bacterial efficacy assessment of acriflavine
title_sort in vitro safety and anti‐bacterial efficacy assessment of acriflavine
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311691/
https://www.ncbi.nlm.nih.gov/pubmed/35322438
http://dx.doi.org/10.1111/all.15289
work_keys_str_mv AT javadiyanshari invitrosafetyandantibacterialefficacyassessmentofacriflavine
AT germeinkittyc invitrosafetyandantibacterialefficacyassessmentofacriflavine
AT cooksleyclarem invitrosafetyandantibacterialefficacyassessmentofacriflavine
AT ramezanpourmahnaz invitrosafetyandantibacterialefficacyassessmentofacriflavine
AT singhnarinder invitrosafetyandantibacterialefficacyassessmentofacriflavine
AT wormaldpeterjohn invitrosafetyandantibacterialefficacyassessmentofacriflavine
AT vreugdesarah invitrosafetyandantibacterialefficacyassessmentofacriflavine
AT psaltisalkisj invitrosafetyandantibacterialefficacyassessmentofacriflavine

Ejemplares similares